Immuron

+$0.09 (+3.59%) Today
-$0.24 (-9.23%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.

About IMRN

Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States.

CEO
Jerry Kanellos
Employees
—
Headquarters
Carlton, Victoria (VIC)
Founded
1994

IMRN Key Statistics

Market cap
14.81M
Price-Earnings ratio
—
Dividend yield
—
Average volume
5.16K
High today
$2.65
Low today
$2.46
Open price
$2.47
Volume
4.54K
52 Week high
$5.20
52 Week low
$2.32

IMRN Earnings

Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Aug 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure